Gene Query: COL4A6

Dataset Description Geneva Score
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 100.39
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 95.39
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 88.7
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 77.94
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 77.94
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 76.77
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 74.85
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 65.55
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 60.89
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 59.63
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 59.02
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 58.78
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 57.28
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 57.04
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 56.74
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 53.63
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 53.63
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 50.07
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 48.98
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 47.61
RNA-seq of shEZH2 cells 46.87
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 45.17
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 39.46
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 39.41
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 39.33
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 38.6
RNA expression following TMPRSS11B overexpression or depletion 37.32
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 37.08
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 37.08
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 35.9
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 35.9
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 35.83
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 34.25
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 33.49
Differential expression of genes in AD169-infected MRC5. 33.19
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 32.88
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 32.66
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 32.12
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 31.63
Overexpression and knockdown experiment for circCSNK1G3 31.4
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 31.26
Fbxo32 mediated gene expression program underlies EMT and metastasis 31.26
G-quadruplex structures mark human regulatory chromatin 31.2
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 30.75
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 30.65
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 30.65
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 30.63
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 30.57
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 30.57
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 30.38
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 30.26
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 29.84
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 29.74
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 29.58
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 29.35
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 29.21
Differential analysis of gene regulation at transcript resolution by RNA-Seq 29.21
RNA-seq analysis of RALD iPSCs after in vitro differentiation 28.89
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 26.48
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 26.37
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 26.1
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 25.9
Disruption of GRIN2B impairs differentiation in human neurons 25.89
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 25.88
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 25.88
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 25.78
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 25.44
Transcriptomic and gene ontology profiling of the human corneal cell types 24.9
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 24.63
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 24.63
Subtle asymmetry of gene expression in embryonic and foetal human brains 23.91
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 23.75
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 23.55
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 23.48
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 23.25
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 22.87
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 22.82
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 22.5
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 22.01
ARS2 is a general suppressor of pervasive transcription [RNAseq] 21.87
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 21.83
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 21.81
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 21.68
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 21.68
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 21.53
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 21.48
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 21.35
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 21.11
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 21.06
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 21.02
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 21.02
A prostate cancer chromatin interaction map 21.02
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 20.97
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 20.94
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 20.94
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 20.75
20.37
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 20.24
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 20.12
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 19.96
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 19.75
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 19.35
Lineage specific differentiation is influenced by state of human pluripotency 19.35
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 18.77
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 18.57
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 18.56
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 18.35
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 17.93
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 17.93
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 17.8
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 17.77
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 17.77
METTL3 promotes translation in human cancer cells 17.72
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 17.68
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 17.53
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 17.52
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 17.48
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 17.24
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 17.22
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 17.21
BAF controls genome accessibility 17.15
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 17.1
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 16.85
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 16.54
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 16.35
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 16.2
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 16.1
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 15.96
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 15.89
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 15.77
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 15.74
Nucleoporin-mediated regulation of cell identity genes 15.42
Accurate annotation of human protein-coding small open reading frames 15.38
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 15.26
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 15.23
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 15.23
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 15.22
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 15.18
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 14.97
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 14.91
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 14.9
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 14.9
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 14.74
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 14.5
AMPK signaling for naïve pluripotency [Hs] 14.47
AMPK signaling for naïve pluripotency 14.47
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 14.44
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 14.44
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 14.39
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 14.33
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 14.28
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 14.28
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 13.96
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 13.65
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 13.61
Identification of Atrial Fibrillation associated genes and functional non-coding variants 13.51
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 13.49
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 13.4
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 13.38
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 13.34
Transcriptome profiling of Normal and Cancerous Prostate Cells 13.28
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 13.26
MEIS1 regulates hematopoiesis in hPSCs 13.25
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 13.24
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 13.2
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 13.09
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 12.9
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 12.83
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 12.75
Evolution of a transcriptional regulator from a transmembrane nucleoporin 12.71
RNA-seq in HepG2 and IMR90 cells 12.71
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 12.68
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 12.58
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 12.57
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 12.52
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 12.36
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 12.34
The effect of Abl kinases on non-small cell carcinoma global transcriptome 12.3
hESC neural differentiation 12.29
RNA-seq analysis of gene expression patterns during hESC neural differentiation 12.29
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 12.29
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 12.19
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 11.98
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 11.94
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 11.85
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 11.8
Mechanistic Model-Guided Study of Embryonic Morphogenesis 11.78
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 11.57
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 11.56
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 11.41
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 11.29
RNA Seq of HMVEC under hypoxia 11.21
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 11.21
Role of FGFR1 in neuronal devlopment 11.2
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 11.16
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 11.16
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.16
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 11.07
Control of prostate tumour growth by the long non-coding RNA GHSROS 10.99
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 10.97
RNA-seq of naive and primed ES cells 10.95
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 10.92
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 10.82
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 10.82
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 10.7
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 10.68
Nonpregnant and term pregnant human myometrial tissues 10.68
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 10.66
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 10.61
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 10.6
X-Ray induced DNA-Hydroxymethylation changes 10.59
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 10.59
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 10.58
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 10.56
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 10.55
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 10.52
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 10.52
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 10.5
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 10.5
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.48
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 10.47
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 10.37
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 10.32
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 10.31
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 10.23
Functional astrocytes differentiated from hiPSCs 10.16
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 10.15
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 10.13
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 10.09
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 9.98
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 9.89
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 9.81
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 9.77
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 9.73
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 9.72
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 9.72
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 9.69
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 9.69
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 9.69
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 9.66
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 9.64
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 9.58
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 9.57
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 9.56
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 9.4
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 9.39
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 9.26
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 9.26
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 9.16
Dynamic reorganization of nuclear architecture during human cardiogenesis 9.16
RNA-seq of human fibroblasts after irradiation 9.15
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 9.06
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.01
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.01
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 9.0
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 8.97
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  8.92
Differential Gene Expression between MCF10A and MCF7 cells 8.91
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 8.66
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.66
SETBP1-WT and SETBP1-G870S epigenetic landscapes 8.65
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 8.65
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 8.44
miRNAs affected by antagomiR-17 treatment 8.41
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 8.36
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 8.35
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 8.35
Next Generation Sequencing of human SMA and healthy control Motor Neurons 8.3
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 8.3
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 8.27
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 8.23
Splicing and epigenetic factors jointly regulate epidermal differentiation 8.22
Identification of Nrf2 regulated genes by RNA sequencing 8.18
Nrf2 regulated genes in A549 cells 8.18
Rorc disruption in human FG pancreatic cancer cells 8.13
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.11
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 8.08
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 8.05
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 8.01
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 8.01
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 7.97
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 7.93
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.9
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.9
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 7.9
PNET animal model: new insights (II) 7.88
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 7.87
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 7.85
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 7.84
hnRNP C is a key regulator of protein synthesis in mitosis 7.83
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.81
circRNA profile in hypopharyngeal cancer 7.78
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 7.75
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 7.73
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 7.73
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.67
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 7.63
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 7.63
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 7.61
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 7.61
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 7.57
Finding missing proteins from epigenetically manipulated human cells 7.55
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.55
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.55
FOXP2's impact on the primate transcriptome 7.36
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 7.36
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 7.34
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.32
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 7.3
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 7.24
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 7.09
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 7.09
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 7.09
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 7.08
Tyrosine Kinase Inhibitor Cardiotoxicity 7.08
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 7.02
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 6.97
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 6.94
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 6.88
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 6.85
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 6.76
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 6.72
Derivation and differentiation of haploid human embryonic stem cells 6.69
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 6.69
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.66
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.66
p63 controls the enhancer landscape during keratinocyte differentiation 6.65
Dissecting neural differentiation regulatory networks through epigenetic footprinting 6.63
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 6.6
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 6.58
FGF2 regulation of gene expression in stable inducible Neurons 6.54
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 6.49
CSL 6.46
CSL RNA-Seq on HKC and SCC cell lines 6.46
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 6.45
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 6.45
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.43
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 6.4
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 6.34
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 6.29
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 6.29
MARS Seq data from human cortical organoids 6.24
Zika virus directly infects human peripheral neurons and induces cell death 6.22
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 6.14
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 6.13
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 6.12
RNA-seq of MCF10A cells and CAF 6.12
Examining serotonergic neuron differentiation from human iPSCs 6.06
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.83
In vitro modeling of human germ cell development using pluripotent stem cells 5.79
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 5.78
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 5.75
Activity-dependent transcriptional changes in human neurons 5.74
TGF-β regulation of miRNA expression in pancreatic cancer 5.7
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 5.69
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 5.69
Generation of KRAS signatures using immortalized isogenic lung cells. 5.69
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 5.57
BI Human Reference Epigenome Mapping Project 5.53
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 5.52
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 5.51
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.47
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.47
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 5.38
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 5.38
Transcriptome analysis upon C6orf203 silencing 5.35
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 5.27
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 5.14
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.05
Human embryonic stem cells in E8 and AKIT culture medium 5.02
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 5.02
JAK dependent survival of ALK- ALCL 4.97
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.72
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 4.71
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 4.71
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 4.69
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 4.66
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 4.59
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 4.59
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.55
UBC9 knockdown in bladder cancer T24 cell lines 4.54
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.52
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 4.48
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.46
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.46
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 4.43
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.38
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.38
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 4.36
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.33
RNA-Seq of Breast and Ovarian Cancer Cell Lines 4.29
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.2
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.2
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.18
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 4.11
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 4.09
Molecular Criteria for Defining the Naive Human Pluripotent State 4.06
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.01
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 3.93
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 3.93
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 3.83
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 3.77
3.74
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 3.73
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.6
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.6
Transcriptome analysis of human lung epithelial cells 3.56
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.55
Morphological and molecular characterization of human dermal lymphatic collectors 3.4
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.39
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 3.37
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.31
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 3.3
NHLRC1 re-expression in cancer cells 3.21
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.17
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.15
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.15
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 3.04
MRTF activates TEAD-YAP target gene expression 3.01
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.95
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.95
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.93
Expression profiling of etoposide-induced senescent cells 2.88
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.82
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 2.81
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.79
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.79
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 2.76
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 2.76
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.73
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 2.71
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 2.7
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 2.69
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.67
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 2.64
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.6
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.57
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.57
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.48
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 2.26
Global transcriptome analysis of WT versus HEB-/- hESCs 2.25
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.19
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 2.09
Gene expression analysis of human liver progenitor-like cells in culture 2.03
RNA Sequencing of Human iPS derived Cardiomyocytes 1.94
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.91
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.81
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.77
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.77
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.77
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.76
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.76
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.76
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.69
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.55
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.44
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 1.44
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.44
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 1.4
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 1.37
Engineering Patient-Specific Tissue Implants 1.35
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.33
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.33
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.31
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  1.29
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.27
Gene expression patterns define the hepatocyte-like cells derived by different strategies 1.14
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 1.14
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.09
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.08
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.02
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 0.96
Epigenomic conservation of transposable element silencing [RNA-seq] 0.93
Epigenomic conservation of transposable element silencing 0.93
Epigenome regulation during epidermal lineage commitment 0.91
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.85
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.84
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 0.82
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.81
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.81
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.79
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 0.77
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.72
hNSCs siRNA NOVA2 0.65
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.59
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.56
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.52
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.49
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.38
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.33
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.26
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.25
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.25
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.25
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.22
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.22
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.07
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.0
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation